tiprankstipranks
Trending News
More News >
Celon Pharma SA (PL:CLN)
:CLN
Poland Market
Advertisement

Celon Pharma SA (CLN) Dividend Date & History

Compare
0 Followers
Celon Pharma SA (PL:CLN) has no upcoming dividends

Dividend Amount Per Share​

CLN Dividend History

Ex-Date
Record Date
Payment Date
Frequency
Declaration Date
Amount
Jun 27, 2024
Jun 28, 2024
Jul 04, 2024
Annuallyzł0.30
Jun 29, 2023
Jun 30, 2023
Jul 06, 2023
Annuallyzł0.33
Jun 30, 2022
Jul 01, 2022
Jul 11, 2022
Annuallyzł0.29
Jul 14, 2021
Jul 15, 2021
Aug 05, 2021
Annuallyzł0.26
Jun 01, 2020
Jun 02, 2020
Jun 19, 2020
Annuallyzł0.30
Apr 29, 2019
Apr 30, 2019
May 13, 2019
Annuallyzł0.89
Jun 11, 2018
Jun 12, 2018
Jun 25, 2018
Annuallyzł0.63
May 31, 2017
Jun 01, 2017
Jun 14, 2017
Annuallyzł0.63
The table shows Celon Pharma SA’s dividend history, including amount per share, payout frequency, declaration, record, and payment dates.

FAQ

How much is Celon Pharma SA's dividend?
PL:CLN pays a dividend of zł0.298 per share. PL:CLN's annual dividend yield is 0.37%.
    When is Celon Pharma SA ex-dividend date?
    Celon Pharma SA's previous ex-dividend date was on Jun 27, 2024. Celon Pharma SA shareholders who own PL:CLN stock before this date received Celon Pharma SA's last dividend payment of zł0.3 per share on Jul 04, 2024. PL:CLN's next ex-dividend date has not been announced yet.
      When is Celon Pharma SA dividend payment date?
      Celon Pharma SA’s next quarterly payment date is on Jul 04, 2024, when Celon Pharma SA shareholders who owned PL:CLN shares before Jun 27, 2024 received a dividend payment of zł0.3 per share. Add PL:CLN to your watchlist to be reminded of PL:CLN's next dividend payment.
        Does Celon Pharma SA have sufficient earnings to cover their dividend?
        The Celon Pharma SA has paid a dividend in the last year and may provide dividends in the near future.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis